http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107344934-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-06 |
| filingDate | 2016-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107344934-B |
| titleOfInvention | Solid forms of pharmaceutically active substances |
| abstract | The invention discloses a compound N-(5-((4-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinoline-1-yl)pyrimidine-1) represented by formula I 2-yl)amino)-2-((2-(dimethylamino)ethyl)methylamino)-4-methoxyphenyl)acrylamide solid form and preparation method thereof, the solid form has high stability , which is an EGFR (surface growth factor receptor) tuner in medicine, can be used for the prevention and treatment of diseases mediated by certain variant surface growth factor receptors. |
| priorityDate | 2016-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.